We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IP:MILInterpump Group S.p.A. Analysis

Data as of 2026-08-08 - not real-time

€38.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Interpump Group S.p.A. is priced at €38.18, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 10.7%. RSI sits at 68.5, which reads as approaching overbought, and MACD momentum is bullish. Recent trading has carved out support near €32.54 and resistance around €39.00.
Valuation screens as undervalued: a P/E of 19.5 sits below the sector average of 30.7. Analyst price targets sit 22.3% above the current price. The 0.92% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 30.1%, a beta of 0.66 and a maximum drawdown of 39.3%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Yahoo Finance2monINTERPUMP GROUP SPA IP.VI Q1 FY2026 earnings call transcriptEarnings call Interpump delivered Q1 2026...Yahoo Finance5monInterpump Group SpA MIL:IP Q4 2025: Everything You Need to Know Ahead of EarningsBased on the one-year...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 39.39
  • MACD momentum is positive
  • 30-day price change of +10.7%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 19.5 versus sector average of 30.7
  • Trading below the 200-day average of 39.39
  • Analyst targets imply +22.3% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 19.5 versus sector average of 30.7
  • Analyst targets imply +22.3% versus the current price
  • Dividend yield of 0.92%

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin10.22%
P/E Ratio19.5
ROE10.25%
ROA5.96%
Debt/Equity31.20
P/B Ratio1.9
Op. Cash Flow€341.6M
Free Cash Flow€188.5M
Industry P/E30.7

Technical Analysis

TrendNeutral
RSI68.5
Support€32.54
Resistance€39.00
MA 20€35.27
MA 50€34.77
MA 200€39.39
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair Value€21.16
Target Price€46.69
Upside/Downside22.28%
GradeUndervalued
TypeBlend
Dividend Yield0.92%

Risk Assessment

Beta0.66
Volatility30.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.